Veljko Kopjar is a seasoned clinical development professional currently serving as Senior Director of Clinical Development at Caidya since June 2021, overseeing a diverse global portfolio of trials across oncology, cardiovascular, CNS, and rare diseases. Additionally, Veljko works as a Clinical Research Consultant for Guidepoint, providing expert advice on clinical trial costs and vendor strategies. Previously, Veljko held the position of Director of Clinical Operations at Nor Consult LLC, managing a team of clinical research professionals, and served as Clinical Project Manager at Sarah Cannon Research Institute, overseeing Phase 1 and Phase 2 trials in collaboration with AstraZeneca. Veljko holds a Master of Arts in Organizational Leadership from Marist University, a Graduate Certificate in Advanced Project Management from Stanford University, and a Bachelor of Arts from Washington State University.
This person is not in any teams
This person is not in any offices